Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. | Director | Common Stock | 239K | $172K | $0.72 | Mar 31, 2024 | Direct |
Atara Biotherapeutics, Inc. | Director | Non-Qualified Stock Option (Right to Buy) | 79.5K | May 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATRA | Atara Biotherapeutics, Inc. | Mar 31, 2024 | 1 | $0 | 4 | Apr 2, 2024 | Director |
ATRA | Atara Biotherapeutics, Inc. | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 23, 2022 | 2 | $0 | 4 | Jun 27, 2022 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 8, 2021 | 2 | $0 | 4 | Jun 9, 2021 | Director |